0

Journal Articles

in Psychopharmacology
 1-20 of 28 Articles
Original Contribution |  April 03, 2013
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy:  A Randomized Clinical Trial
Ellen M. Lavoie Smith, PhD; Herbert Pang, PhD; Constance Cirrincione, MS; et al.
JAMA. 2013;309(13):1359-1367. doi:10.1001/jama.2013.2813.
INCLUDES: CME , Supplemental Content
Research Letters |  February 20, 2013
Pharmaceutical Overdose Deaths, United States, 2010
Christopher M. Jones, PharmD; Karin A. Mack, PhD; Leonard J. Paulozzi, MD
JAMA. 2013;309(7):657-659. doi:10.1001/jama.2013.272.
Capitol Health Call |  February 13, 2013
Children’s Mental Health
Mike Mitka, MSJ
JAMA. 2013;309(6):535. doi:10.1001/jama.2013.466.
Research Letters |  February 06, 2013
Antipsychotic Use Among Nursing Home Residents
Becky A. Briesacher, PhD; Jennifer Tjia, MD, MSCE; Terry Field, DSc; et al.
JAMA. 2013;309(5):440-442. doi:10.1001/jama.2012.211266.
Medical News and Perspectives |  January 23, 2013
Researchers Seek New Ways to Counter the Harmful Toll of Stress on the Brain
M. J. Friedrich
JAMA. 2013;309(4):330-332. doi:10.1001/jama.2012.174455.
Lab Reports |  January 02, 2013
Lithium for Down Syndrome
Tracy Hampton, PhD
JAMA. 2013;309(1):20. doi:10.1001/jama.2012.173444.
Original Contribution |  January 02, 2013
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
Olof Stephansson, MD, PhD; Helle Kieler, MD, PhD; Bengt Haglund, PhD; et al.
JAMA. 2013;309(1):48-54. doi:10.1001/jama.2012.153812.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  December 19, 2012 FREE
A Trip on “Bath Salts” Is Cheaper Than Meth or Cocaine But Much More Dangerous
Anita Slomski
JAMA. 2012;308(23):2445-2447. doi:10.1001/jama.2012.34423.
Capitol Health Call |  November 14, 2012
Overprescribing Antipsychotics
Mike Mitka, MSJ
JAMA. 2012;308(18):1849. doi:10.1001/jama.2012.33462.
Health Agencies Update |  September 26, 2012
Off-label Atypical Antipsychotics
Bridget M. Kuehn
JAMA. 2012;308(12):1198. doi:10.1001/2012.jama.12018.
Users' Guides to the Medical Literature |  September 26, 2012
How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis
Edward J. Mills, PhD, MSc; John P. A. Ioannidis, MD, DSc; Kristian Thorlund, PhD, MSc; et al.
JAMA. 2012;308(12):1246-1253. doi:10.1001/2012.jama.11228.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  July 11, 2012
CMS Seeks to Reduce Antipsychotic Use in Nursing Home Residents With Dementia
Mike Mitka
JAMA. 2012;308(2):119-121. doi:10.1001/jama.2012.7422.
Original Contribution |  September 21, 2011 FREE
Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder:  The Pediatric OCD Treatment Study II (POTS II) Randomized Controlled Trial
Martin E. Franklin, PhD; Jeffrey Sapyta, PhD; Jennifer B. Freeman, PhD; et al.
JAMA. 2011;306(11):1224-1232. doi:10.1001/jama.2011.1344.
INCLUDES: , Supplemental Content
Review |  January 06, 2010 FREE
Antidepressant Drug Effects and Depression Severity:  A Patient-Level Meta-analysis
Jay C. Fournier, MA; Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; et al.
JAMA. 2010;303(1):47-53. doi:10.1001/jama.2009.1943.
INCLUDES: , Supplemental Content
Capitol Health Call |  June 10, 2009
Enhancing FDA Inspections
Mike Mitka
JAMA. 2009;301(22):2318. doi:10.1001/jama.2009.782.
Capitol Health Call |  May 13, 2009
Unbiased Drug Information
Mike Mitka
JAMA. 2009;301(18):1868. doi:10.1001/jama.2009.606.
Capitol Health Call |  September 17, 2008
Academic Detailing Bill
Mike Mitka
JAMA. 2008;300(11):1290. doi:10.1001/jama.300.11.1290-c.
Commentary |  March 05, 2008
The Loss of Serendipity in Psychopharmacology
Donald F. Klein, MD, DSc
JAMA. 2008;299(9):1063-1065. doi:10.1001/jama.299.9.1063.
Medical News and Perspectives |  February 14, 2007
FDA Panel Seeks to Balance Risks in Warnings for Antidepressants
JAMA. 2007;297(6):573-580. doi:10.1001/jama.297.6.573.
The World in Medicine |  May 17, 2006
Reducing Phobias
JAMA. 2006;295(19):2240. doi:10.1001/jama.295.19.2240-b.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Psychiatry
Original Article  |  March 27, 2013
Effects of Varenicline and Bupropion Sustained-Release Use Plus Intensive Smoking Cessation Counseling on Prolonged Abstinence From Smoking and on Depression, Negative Affect, and Other Symptoms of Nicotine Withdrawal
Paul M. Cinciripini, PhD; Jason D. Robinson, PhD; Maher Karam-Hage, MD; et al.
JAMA Internal Medicine
Original Investigation  |  April 29, 2013
Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery
Andrew D. Auerbach, MD, MPH; Eric Vittinghoff, PhD; Judith Maselli, MSPH; et al.
JAMA Internal Medicine
Invited Commentary  |  April 29, 2013
Selective Serotonin Reuptake Inhibitors and Surgery: To Hold or Not to Hold, That Is the Question:  Comment on “Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery”
Marko Mrkobrada, MD, FRCPC; Daniel G. Hackam, MD, PhD, FRCPC
JAMA Internal Medicine
Review Article  |  March 4, 2013
Pharmacologic Therapy for Primary Restless Legs Syndrome:  A Systematic Review and Meta-analysis
Timothy J. Wilt, MD, MPH; Roderick MacDonald, MS; Jeannine Ouellette; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems